Progression of pulmonary veno-occlusive disease without pulmonary hypertension.
Sarah BeshayMarc HumbertRoberto BarriosAdriano R TonelliPublished in: Pulmonary circulation (2022)
Pulmonary veno-occlusive disease (PVOD) is a progressively fatal disease with no definitive treatment options. PVOD can be a result of genetic mutation but can also be due secondary to exposure to solvents or chemotherapeutic agents. Generally, at the time of diagnosis PVOD is associated with hemodynamically confirmed pulmonary hypertension (PH). In this study, we describe a patient who was diagnosed with PVOD early in the disease without hemodynamically confirmed PH. She had histologically confirmed PVOD. Her clinical presentation posed management challenges and prednisone therapy was used to stabilize her disease. This case and some recently published reports highlight possible immune dysregulation in PVOD and role for immuno-suppressive therapy in these patients.
Keyphrases
- pulmonary hypertension
- end stage renal disease
- pulmonary artery
- extracorporeal membrane oxygenation
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- pulmonary arterial hypertension
- systematic review
- squamous cell carcinoma
- emergency department
- peritoneal dialysis
- case report
- coronary artery
- sickle cell disease
- replacement therapy
- patient reported
- cell therapy